Table 4 Relationship between CCT2 and PDIA3 expression and clinicopathological characteristics and average survival of gallbladder SC/ASC patients

Gender

male

19

10.74(6 to 24)

0.767

0.381

female

27

9.85(4 to 24)

Age (years)

≤45

3

15.67(8 to 24)

2.023

0.155

>45

43

9.84(4 to 24)

Pathological types

SC

26

10.19(4 to 24)

0.223

0.637

ASC

20

10.25(4 to 24)

Degree of differentiation^a

well-differentiated

16

7.04(4 to 11)

moderately-Differentiated

24

8.92(4 to 18)

19.125

0.000

poorly-differentiated

6

5.83(4 to 9)

Tumor maximum diameter (cm)

≤ 3 cm

20

14.35(7 to 24)

31.337

0.620

> 3 cm

26

7.04(4 to 11)

Gallbladder stones

no

18

8.22(4 to 12)

3.730

0.053

yes

28

11.50(4 to 24)

TNM stage

I + II

12

17.00(9 to 24)

III

20

9.20(7 to 15)

51.139

0.000

IV

14

5.86(4 to 8)

Lymph node metastasis

no

17

14.24(4 to 24)

16.219

0.000

yes

29

7.86(4 to 15)

Invasion

no

16

15.75(9 to 24)

32.271

0.000

yes

30

7.27(4 to 12)

Surgical

radical

16.64(10 to 24)

palliative

8.50(6 to 12)

50.165

0.000

biopsy

6.00(4 to 8)

CCT2

-

23

12.96(6 to 24)

14.073

0.000

+

33

7.48(4 to 12)

PDIA3

-

20

12.75(6 to 24)

7.011

0.008

+

26

8.27(4 to 24)